Dolby Laboratories (DLB) Projected to Post Quarterly Earnings on Thursday

Dolby Laboratories (NYSE:DLB) is expected to be issuing its Q1 2026 results after the market closes on Thursday, January 29th. Analysts expect the company to announce earnings of $0.90 per share and revenue of $341.2590 million for the quarter. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. Investors can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, January 29, 2026 at 5:00 PM ET.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, beating analysts’ consensus estimates of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The company had revenue of $307.02 million for the quarter, compared to analyst estimates of $305.76 million. During the same period last year, the company earned $0.61 earnings per share. The company’s quarterly revenue was up .7% compared to the same quarter last year. On average, analysts expect Dolby Laboratories to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Dolby Laboratories Stock Up 0.8%

Shares of NYSE DLB opened at $62.15 on Thursday. The stock has a market cap of $5.94 billion, a P/E ratio of 23.63 and a beta of 0.88. The firm’s 50-day simple moving average is $65.53 and its 200 day simple moving average is $69.47. Dolby Laboratories has a fifty-two week low of $61.33 and a fifty-two week high of $89.66.

Dolby Laboratories Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd were given a dividend of $0.36 per share. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date was Tuesday, December 2nd. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.3%. Dolby Laboratories’s payout ratio is presently 54.75%.

Insider Buying and Selling at Dolby Laboratories

In other news, EVP Mark Andrew Sherman sold 2,491 shares of the firm’s stock in a transaction on Wednesday, December 17th. The stock was sold at an average price of $67.26, for a total transaction of $167,544.66. Following the completion of the sale, the executive vice president directly owned 70,563 shares of the company’s stock, valued at $4,746,067.38. This trade represents a 3.41% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Kevin J. Yeaman sold 6,751 shares of Dolby Laboratories stock in a transaction on Wednesday, December 17th. The stock was sold at an average price of $67.24, for a total value of $453,937.24. Following the completion of the transaction, the chief executive officer owned 98,377 shares in the company, valued at $6,614,869.48. The trade was a 6.42% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 137,120 shares of company stock valued at $9,184,809. 37.93% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Dolby Laboratories

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Royal Bank of Canada increased its stake in Dolby Laboratories by 3.5% in the 1st quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock worth $5,491,000 after purchasing an additional 2,298 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of Dolby Laboratories by 218.8% in the first quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock worth $20,043,000 after buying an additional 171,288 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Dolby Laboratories by 5.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker’s stock worth $19,131,000 after acquiring an additional 12,598 shares in the last quarter. Focus Partners Wealth acquired a new stake in shares of Dolby Laboratories during the first quarter valued at approximately $390,000. Finally, EverSource Wealth Advisors LLC raised its holdings in shares of Dolby Laboratories by 273.3% during the second quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock valued at $193,000 after acquiring an additional 1,902 shares during the period. Institutional investors and hedge funds own 58.56% of the company’s stock.

Analysts Set New Price Targets

DLB has been the subject of several recent analyst reports. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Monday, January 5th. Barrington Research cut their target price on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research report on Wednesday, November 19th. Rosenblatt Securities decreased their price target on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, November 19th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Monday, December 29th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $92.00.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.